Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
暂无分享,去创建一个
A. Tutt | N. Loman | R. Schmutzler | J. Carmichael | M. Friedlander | U. Matulonis | J. Weitzel | M. Audeh | R. Penson | B. Powell | K. Bell-McGuinn | C. Scott | A. Oaknin | K. Lu | M. Wickens